U. Landmesser in conversation with S. Nicholls: SATURN- Comparison of the Progression of Coronary Atherosclerosis for Two High Efficacy Statin Regimens with Different HDL Effects

U. Landmesser in conversation with with S. Nicholls and D. Radar: Evacetrapid and Lipid-Modulating Effects

U. Landmesser in conversation with A. Kastrati and D. Bhatt: ISAR-REACT- Abciximab Plus Unfractionated Heparin versus Bivalirudin in Patients with Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

M. Sabate and W. Wijns in conversation with U. Landmesser on The Examination Trial
August 2011

Ulf Landmesser in conversation with K. Fox & S. Hohnloser:
ROCKET AF - Rivaroxaban versus Warfarin in nonvalvular AF

Ulrich Laufs and Philip Barter in conversation with Ulf Landmesser:
Post-prandial triglycerides and CV events in CAD

Stefanie Dimmeler in conversation with Ulf Landmesser:
MicroRNAs: novel therapeutic targets in CV diseases

Patrick Serruys in conversation with Ulf Landmesser:
Biodegradable drug eluting scaffold - the 4th revolution

Andreas Zeiher in conversation with Ulf Landmesser:
Stem cells - An Update

Helmut Baumgartner in conversation with Ulf Landmesser:
GUCH : The new ESC Guidelines